Skip to content
Israeli Founders

biotech

Splisense

Antisense-oligonucleotide therapies for genetic diseases caused by splicing mutations, including cystic fibrosis

Total raised
$13M
Funding rounds
1
Headquarters
Jerusalem

Splisense is an Israeli biotech company1, headquartered in Jerusalem1.

It has raised $13M across 1 funding round1; the most recent was a round of $13M1, announced Jun 16, 20261.

Funding history

1 round

Funding rounds raised by Splisense, newest first
RoundAnnouncedAmountLead investors
Undisclosed stageJun 16, 2026$13M

Which Israeli startups are similar to Splisense?

Sources

  1. 1FundedIQ, Jun 16, 2026. “Splisense: Funding, Investors & Team (Oct 2026) | FundedIQ”

How much funding has Splisense raised?

Splisense has raised $13M across 1 funding round.

What was Splisense’s latest funding round?

Splisense’s most recent round was a round of $13M, announced Jun 16, 2026.

Where is Splisense based?

Splisense is based in Jerusalem.